Cargando…

Role of Adiponectin Peptide I (APNp1) in Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is an eye disease that can cause central vision loss, particularly in the elderly population. There are 2 classes of AMD, wet-type and dry-type. Wet-type involves excess angiogenesis around the macula, referred to as choroidal neovascularization (CNV). This can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Logan, Connor, Lyzogubov, Valeriy, Bora, Nalini, Bora, Puran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496372/ https://www.ncbi.nlm.nih.gov/pubmed/36139070 http://dx.doi.org/10.3390/biom12091232

Ejemplares similares

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
por: Choubey, Mayank, et al.
Publicado: (2023)

Emerging Role of Adiponectin/AdipoRs Signaling in Choroidal Neovascularization, Age-Related Macular Degeneration, and Diabetic Retinopathy
por: Choubey, Mayank, et al.
Publicado: (2023)

The role of complement in ocular pathology
por: Bora, Nalini S., et al.
Publicado: (2008)

Oxidative Stress and Antioxidants in Age-Related Macular Degeneration
por: Kushwah, Neetu, et al.
Publicado: (2023)

New Discoveries in Retinal Cell Degeneration and Retinal Diseases
por: Bora, Puran S.
Publicado: (2023)

Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
por: Dikmetas, Ozlem, et al.
Publicado: (2022)

Role of amyloid β-peptide in the pathogenesis of age-related macular degeneration
por: Wang, Minwei, et al.
Publicado: (2021)

The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
por: Dikmetas, Ozlem, et al.
Publicado: (2013)

Prevention of Oxidative Stress-Induced Retinal Pigment Epithelial Cell Death by the PPARγ Agonists, 15-Deoxy-Delta 12, 14-Prostaglandin J(2)
por: Chang, Jason Y., et al.
Publicado: (2008)

Metabolomics and Age-Related Macular Degeneration
por: Brown, Connor N., et al.
Publicado: (2018)

Antigen Specific Tolerance Inhibits Autoimmune Uveitis in Pre-sensitized Animals via Deletion and CD4(+)CD25(+) T-Regulatory Cells
por: Matta, Bharati, et al.
Publicado: (2009)

Complement factor I and age-related macular degeneration
por: Alexander, Philip, et al.
Publicado: (2014)

The Role of Inflammation in Age-Related Macular Degeneration
por: Tan, Wei, et al.
Publicado: (2020)

Oxidative stress in retinal pigment epithelium degeneration: from pathogenesis to therapeutic targets in dry age-related macular degeneration
por: Maurya, Meenakshi, et al.
Publicado: (2023)

The Effect of Age-Related Macular Degeneration on Components of Face Perception
por: Logan, Andrew J., et al.
Publicado: (2020)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration
por: Wu, Tony, et al.
Publicado: (2023)

The Role of the Immune Response in Age-Related Macular Degeneration
por: Whitcup, Scott M., et al.
Publicado: (2013)

Inflammation and its role in age-related macular degeneration
por: Kauppinen, Anu, et al.
Publicado: (2016)

Role of Complement in the Onset of Age-Related Macular Degeneration
por: Piri, Niloofar, et al.
Publicado: (2023)

Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
por: Schmidt-Erfurth, Ursula, et al.
Publicado: (2014)

Peptide redesign for inhibition of the complement system: Targeting age-related macular degeneration
por: Mohan, Rohith R., et al.
Publicado: (2016)

Evaluation of a connexin-based peptide for the treatment of age-related macular degeneration
por: Obert, Elisabeth, et al.
Publicado: (2022)

Pharmacogenetics and Age-Related Macular Degeneration
por: Schwartz, Stephen G., et al.
Publicado: (2011)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Angiogenin in age-related macular degeneration
por: Skeie, Jessica M., et al.
Publicado: (2011)

Pharmacotherapy for Age-Related Macular Degeneration
por: Ahmadieh, Hamid
Publicado: (2008)

Nanotechnology for Age-Related Macular Degeneration
por: Yang, Bo, et al.
Publicado: (2021)

Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

Age-Related Macular or Retinal Degeneration?
por: Gałuszka, Michalina, et al.
Publicado: (2023)

Age-related macular degeneration and the aging eye
por: Ehrlich, Rita, et al.
Publicado: (2008)

Age-Related Macular Degeneration and the Aging Brain
por: Whitson, Heather, et al.
Publicado: (2021)

CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: An Expert Panel Consensus
por: Wong, Tien Yin, et al.
Publicado: (2020)

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
por: Daien, Vincent, et al.
Publicado: (2021)

Update on the role of genetics in the onset of age-related macular degeneration
por: Francis, Peter James, et al.
Publicado: (2011)

The role of CRP and inflammation in the pathogenesis of age-related macular degeneration
por: Colak, Emina, et al.
Publicado: (2012)

Exploring the role of VEGF in Indian Age related macular degeneration
por: Sharma, Kaushal, et al.
Publicado: (2015)

The Question of a Role for Statins in Age-Related Macular Degeneration
por: Roizenblatt, Marina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lrqchircfrqq3548cfmf2qjish